Literature DB >> 32531797

Diagnostic and therapeutic differences between immune checkpoint inhibitor-induced and idiopathic bullous pemphigoid: a cross-sectional study.

G E Molina1,2, K L Reynolds1,3,4, S T Chen1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32531797     DOI： 10.1111/bjd.19313

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

Review 1.  High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer.

Authors:  Alyce M Kuo; Alina Markova
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 2.  Immune-checkpoint inhibitors: long-term implications of toxicity.

Authors:  Douglas B Johnson; Caroline A Nebhan; Javid J Moslehi; Justin M Balko
Journal:  Nat Rev Clin Oncol       Date:  2022-01-26       Impact factor: 65.011

Review 3.  Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management.

Authors:  Zoe Apalla; Bernardo Rapoport; Vincent Sibaud
Journal:  Int J Womens Dermatol       Date:  2021-10-23

Review 4.  Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR.

Authors:  Nicholas L Bayless; Jeffrey A Bluestone; Samantha Bucktrout; Lisa H Butterfield; Elizabeth M Jaffee; Christian A Koch; Bart O Roep; Arlene H Sharpe; William J Murphy; Alexandra-Chloé Villani; Theresa L Walunas
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 12.469

5.  A 72-year-old man with nonhealing facial erosions and bullae.

Authors:  Catherina X Pan; Catherine E Pisano; Mia S DeSimone; Vinod E Nambudiri
Journal:  JAAD Case Rep       Date:  2022-07-20

6.  Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation.

Authors:  Dennis Niebel; Dagmar Wilsmann-Theis; Thomas Bieber; Mark Berneburg; Joerg Wenzel; Christine Braegelmann
Journal:  Dermatopathology (Basel)       Date:  2022-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.